Lantern Pharma Inc.
LTRN
$4.44
-$0.13-2.85%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 15.90M | 19.72M | 24.01M | 28.05M | 33.26M |
Total Receivables | -- | -- | 97.00K | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 931.00K | 601.70K | 1.14M | 1.12M | 1.09M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 368.00K | 500.00K | -- | 748.00K | 935.00K |
Total Current Assets | 17.20M | 20.82M | 25.25M | 29.92M | 35.29M |
|
|||||
Total Current Assets | 17.20M | 20.82M | 25.25M | 29.92M | 35.29M |
Net Property, Plant & Equipment | 182.80K | 236.20K | 287.40K | 335.60K | 263.30K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 36.70K | 36.70K | 36.70K | 36.70K | 32.00K |
Total Assets | 17.42M | 21.10M | 25.57M | 30.29M | 35.59M |
|
|||||
Total Accounts Payable | 3.37M | 2.93M | 2.42M | 2.55M | 2.42M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 131.50K | 161.50K | 190.80K | 197.30K | 164.00K |
Total Finance Division Other Current Liabilities | 1.38M | 1.20M | 1.73M | 855.00K | 2.02M |
Total Other Current Liabilities | 1.38M | 1.20M | 1.73M | 855.00K | 2.02M |
Total Current Liabilities | 4.88M | 4.29M | 4.33M | 3.60M | 4.60M |
|
|||||
Total Current Liabilities | 4.88M | 4.29M | 4.33M | 3.60M | 4.60M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 13.50K | 33.40K | 52.80K | 94.00K | 54.70K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.90M | 4.32M | 4.38M | 3.70M | 4.66M |
|
|||||
Common Stock & APIC | 97.37M | 97.21M | 97.06M | 96.77M | 96.58M |
Retained Earnings | -84.89M | -80.56M | -76.03M | -70.15M | -65.64M |
Treasury Stock & Other | 48.00K | 131.70K | 154.00K | -25.30K | -6.60K |
Total Common Equity | 12.52M | 16.78M | 21.19M | 26.60M | 30.93M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 12.52M | 16.78M | 21.19M | 26.60M | 30.93M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 12.52M | 16.78M | 21.19M | 26.60M | 30.93M |
|